Literature DB >> 21147252

Bone marrow stromal cells (bone marrow-derived multipotent mesenchymal stromal cells) for bone tissue engineering: basic science to clinical translation.

Hideaki Kagami1, Hideki Agata, Arinobu Tojo.   

Abstract

Bone tissue engineering is a promising field of regenerative medicine in which cultured cells, scaffolds, and osteogenic inductive signals are used to regenerate bone. This technology has already been used in several clinical studies and its efficacy has been reported. In this review, we focus on bone marrow stromal cells, which are the most commonly used cell source for bone tissue engineering. The nature of the cells, suitable culture conditions for bone tissue engineering, and their potential therapeutic applications are reviewed with possible caveats. Furthermore, recent advances in bone marrow stromal cell biology are discussed with reference to clinical translation.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Mesh:

Year:  2010        PMID: 21147252     DOI: 10.1016/j.biocel.2010.12.006

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  27 in total

1.  Oxygen Tension-Controlled Matrices with Osteogenic and Vasculogenic Cells for Vascularized Bone Regeneration In Vivo.

Authors:  Ami R Amini; Thomas O Xu; Ramaswamy M Chidambaram; Syam P Nukavarapu
Journal:  Tissue Eng Part A       Date:  2016-03-22       Impact factor: 3.845

2.  Delayed minimally invasive injection of allogenic bone marrow stromal cell sheets regenerates large bone defects in an ovine preclinical animal model.

Authors:  Arne Berner; Jan Henkel; Maria A Woodruff; Roland Steck; Michael Nerlich; Michael A Schuetz; Dietmar W Hutmacher
Journal:  Stem Cells Transl Med       Date:  2015-04-01       Impact factor: 6.940

Review 3.  Bone tissue engineering: recent advances and challenges.

Authors:  Ami R Amini; Cato T Laurencin; Syam P Nukavarapu
Journal:  Crit Rev Biomed Eng       Date:  2012

Review 4.  Umbilical cord-derived mesenchymal stem cells: Their advantages and potential clinical utility.

Authors:  Tokiko Nagamura-Inoue; Haiping He
Journal:  World J Stem Cells       Date:  2014-04-26       Impact factor: 5.326

5.  NIR irradiation of human buccal fat pad adipose stem cells and its effect on TRP ion channels.

Authors:  Leila Gholami; Saeid Afshar; Aliasghar Arkian; Masood Saeidijam; Seyedeh Sareh Hendi; Roghayeh Mahmoudi; Khatereh Khorsandi; Hadi Hashemzehi; Reza Fekrazad
Journal:  Lasers Med Sci       Date:  2022-10-13       Impact factor: 2.555

6.  Dual-function hybrid nanoparticles with gene silencing and anti-inflammatory effects.

Authors:  Oksana Fihurka; Vasyl Sava; Juan Sanchez-Ramos
Journal:  Nanomedicine (Lond)       Date:  2022-04-04       Impact factor: 6.096

7.  Overexpression of Wnt11 promotes chondrogenic differentiation of bone marrow-derived mesenchymal stem cells in synergism with TGF-β.

Authors:  Shuang Liu; Enjiao Zhang; Mingliang Yang; Li Lu
Journal:  Mol Cell Biochem       Date:  2014-01-29       Impact factor: 3.396

8.  Morphology-based prediction of osteogenic differentiation potential of human mesenchymal stem cells.

Authors:  Fumiko Matsuoka; Ichiro Takeuchi; Hideki Agata; Hideaki Kagami; Hirofumi Shiono; Yasujiro Kiyota; Hiroyuki Honda; Ryuji Kato
Journal:  PLoS One       Date:  2013-02-21       Impact factor: 3.240

9.  Dasatinib as a bone-modifying agent: anabolic and anti-resorptive effects.

Authors:  Antonio Garcia-Gomez; Enrique M Ocio; Edvan Crusoe; Carlos Santamaria; Pilar Hernández-Campo; Juan F Blanco; Fermin M Sanchez-Guijo; Teresa Hernández-Iglesias; Jesús G Briñón; Rosa M Fisac-Herrero; Francis Y Lee; Atanasio Pandiella; Jesús F San Miguel; Mercedes Garayoa
Journal:  PLoS One       Date:  2012-04-23       Impact factor: 3.240

10.  A Small Molecule Swertisin from Enicostemma littorale Differentiates NIH3T3 Cells into Islet-Like Clusters and Restores Normoglycemia upon Transplantation in Diabetic Balb/c Mice.

Authors:  Nidheesh Dadheech; Sanket Soni; Abhay Srivastava; Sucheta Dadheech; Shivika Gupta; Renjitha Gopurappilly; Ramesh R Bhonde; Sarita Gupta
Journal:  Evid Based Complement Alternat Med       Date:  2013-04-15       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.